ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,329,000 | -86.2% | 28,684 | -92.7% | 0.03% | -71.9% |
| Q1 2019 | $9,616,000 | +156.4% | 394,398 | +49.9% | 0.11% | +22.6% |
| Q4 2018 | $3,750,000 | -65.9% | 263,170 | -63.6% | 0.09% | -54.4% |
| Q3 2018 | $10,983,000 | -8.1% | 722,543 | +1.5% | 0.20% | -8.5% |
| Q2 2018 | $11,947,000 | -4.1% | 711,962 | -6.7% | 0.22% | -8.2% |
| Q1 2018 | $12,460,000 | +214.8% | 763,467 | +146.9% | 0.24% | +242.3% |
| Q4 2017 | $3,958,000 | +26.1% | 309,188 | -53.4% | 0.07% | +22.4% |
| Q4 2014 | $3,139,000 | – | 663,662 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,850,650 | $75,330,000 | 5.64% |
| BVF INC/IL | 6,682,711 | $28,201,000 | 4.81% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,729,361 | $36,838,000 | 1.49% |
| First Light Asset Management, LLC | 530,391 | $2,238,000 | 0.94% |
| KOPP INVESTMENT ADVISORS LLC | 376,477 | $1,589,000 | 0.78% |
| Sarissa Capital Management LP | 700,000 | $2,954,000 | 0.57% |
| Orbimed Advisors | 10,689,000 | $45,108,000 | 0.41% |
| Bedell Frazier Investment Counselling, LLC | 178,971 | $755,000 | 0.37% |
| PINNACLE ASSOCIATES LTD | 3,453,487 | $14,574,000 | 0.31% |
| Artal Group S.A. | 3,710,000 | $15,656,000 | 0.29% |